Elanco Animal Health Inc
NYSE:ELAN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11.34
18.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Elanco Animal Health Inc
Wall Street
Price Targets
ELAN Price Targets Summary
Elanco Animal Health Inc
According to Wall Street analysts, the average 1-year price target for
ELAN
is 19.509 USD
with a low forecast of 15.15 USD and a high forecast of 23.1 USD.
ELAN Last Price Targets
Elanco Animal Health Inc
The latest public price target was made on Sep 23, 2024 by
Balaji Prasad
from
Barclays
,
who expects
ELAN
stock to
rise by 58%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Balaji Prasad
Barclays
|
22
USD
Upside 58% |
1 month ago
Sep 23, 2024
|
Elanco price target raised to $22 from $21 at Barclays
TheFly
|
David Westenberg
Piper Sandler
|
16
USD
Upside 15% |
4 months ago
Jul 1, 2024
|
Elanco price target lowered to $16 from $19 at Piper Sandler
TheFly
|
|
David Westenberg
Piper Sandler
|
19
USD
Upside 37% |
6 months ago
May 13, 2024
|
Elanco Animal Health (ELAN) PT Raised to $19 at Piper Sandler
StreetInsider
|
|
David Westenberg
Piper Sandler
|
18
USD
Upside 29% |
8 months ago
Mar 12, 2024
|
Elanco Animal Health (ELAN) PT Raised to $18 at Piper Sandler
StreetInsider
|
Price Targets
Operating Income
Forecast
Operating Income Estimate
Elanco Animal Health Inc
For the last 8 years the
compound annual growth rate for
Elanco Animal Health Inc's operating income is
67%.
The projected
CAGR
for the next 3 years is
39%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ELAN's stock price target?
Price Target
19.509
USD
According to Wall Street analysts, the average 1-year price target for
ELAN
is 19.509 USD
with a low forecast of 15.15 USD and a high forecast of 23.1 USD.
What is Elanco Animal Health Inc's Revenue forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
Elanco Animal Health Inc's revenue is
5%.
The projected
CAGR
for the next 3 years is
3%.
What is Elanco Animal Health Inc's Operating Income forecast?
Projected CAGR
39%
For the last 8 years the
compound annual growth rate for
Elanco Animal Health Inc's operating income is
67%.
The projected
CAGR
for the next 3 years is
39%.
You don't have any saved screeners yet
